PARC Antibodies

Santa Cruz Biotechnology features a diverse variety of PARC Antibodies for advanced research in cellular signaling and regulation. PARC Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PARC, or the P53-Associated Protein with a Regulatory Role in Cell Cycle, plays a critical role in the regulation of cell proliferation and apoptosis, maintaining cellular homeostasis. PARC involvement in tumor suppression and response to DNA damage highlights its significance in cancer research and therapeutic development. Understanding PARC function provides valuable insights into various pathological conditions, including cancer and neurodegenerative diseases. Researchers worldwide rely on PARC monoclonal antibodies to investigate cellular pathways and molecular mechanisms. Advanced detection methods, including horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC) conjugates, enable precise visualization and quantification of PARC expression. Santa Cruz Biotechnology monoclonal antibodies for PARC research support scientists in making meaningful discoveries that advance our understanding of human health and disease.